| Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19 MGP van der Wijst, SE Vazquez, GC Hartoularos, P Bastard, T Grant, ... Science translational medicine 13 (612), eabh2624, 2021 | 172 | 2021 |
| Gut microbiota–specific IgA+ B cells traffic to the CNS in active multiple sclerosis AK Pröbstel, X Zhou, R Baumann, S Wischnewski, M Kutza, OL Rojas, ... Science immunology 5 (53), eabc7191, 2020 | 154 | 2020 |
| Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms E Song, CM Bartley, RD Chow, TT Ngo, R Jiang, CR Zamecnik, ... Cell Reports Medicine 2 (5), 2021 | 152 | 2021 |
| A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis A Ramesh, RD Schubert, AL Greenfield, R Dandekar, R Loudermilk, ... Proceedings of the National Academy of Sciences 117 (37), 22932-22943, 2020 | 134 | 2020 |
| Decreased DGCR8 expression and miRNA dysregulation in individuals with 22q11. 2 deletion syndrome C Sellier, VJ Hwang, R Dandekar, B Durbin-Johnson, ... PloS one 9 (8), e103884, 2014 | 92 | 2014 |
| Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine–induced antibody and T cell immunity and function JJ Sabatino Jr, K Mittl, WM Rowles, K McPolin, JV Rajan, MT Laurie, ... JCI insight 7 (4), 2022 | 68 | 2022 |
| A specific amino acid motif of HLA-DRB1 mediates risk and interacts with smoking history in Parkinson’s disease JA Hollenbach, PJ Norman, LE Creary, V Damotte, G Montero-Martin, ... Proceedings of the National Academy of Sciences 116 (15), 7419-7424, 2019 | 64 | 2019 |
| Allele-Level KIR Genotyping of More Than a Million Samples: Workflow, Algorithm, and Observations I Wagner, D Schefzyk, J Pruschke, G Schöfl, B Schöne, N Gruber, K Lang, ... Frontiers in immunology 9, 2843, 2018 | 57 | 2018 |
| Anti–SARS-CoV-2 and autoantibody profiles in the cerebrospinal fluid of 3 teenaged patients with COVID-19 and subacute neuropsychiatric symptoms CM Bartley, C Johns, TT Ngo, R Dandekar, RL Loudermilk, BD Alvarenga, ... JAMA neurology 78 (12), 1503-1509, 2021 | 42 | 2021 |
| Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis AL Greenfield, R Dandekar, A Ramesh, EL Eggers, H Wu, S Laurent, ... JCI insight 4 (6), 2019 | 33 | 2019 |
| Intrathecal B-cell activation in LGI1 antibody encephalitis K Lehmann-Horn, SR Irani, S Wang, A Palanichamy, S Jahn, ... Neurology: Neuroimmunology & Neuroinflammation 7 (2), e669, 2020 | 26 | 2020 |
| Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity JJ Sabatino Jr, K Mittl, W Rowles, K Mcpolin, JV Rajan, CR Zamecnik, ... medRxiv, 2021 | 23 | 2021 |
| High-Resolution Characterization of KIR Genes in a Large North American Cohort Reveals Novel Details of Structural and Sequence Diversity LM Amorim, DG Augusto, N Nemat-Gorgani, G Montero-Martin, WM Marin, ... Frontiers in Immunology 12, 674778, 2021 | 23 | 2021 |
| Report from the Killer-cell Immunoglobulin-like Receptors (KIR) component of the 17th International HLA and Immunogenetics Workshop MK Misra, DG Augusto, GM Martin, N Nemat-Gorgani, J Sauter, ... Human immunology 79 (12), 825-833, 2018 | 21 | 2018 |
| High-throughput interpretation of killer-cell immunoglobulin-like receptor short-read sequencing data with PING WM Marin, R Dandekar, DG Augusto, T Yusufali, B Heyn, J Hofmann, ... PLoS computational biology 17 (8), e1008904, 2021 | 20 | 2021 |
| Fluctuating and geographically specific selection characterize rapid evolution of the human KIR region DG Augusto, PJ Norman, R Dandekar, JA Hollenbach Frontiers in Immunology 10, 454505, 2019 | 19 | 2019 |
| Exploratory neuroimmune profiling identifies CNS-specific alterations in COVID-19 patients with neurological involvement E Song, CM Bartley, RD Chow, TT Ngo, R Jiang, CR Zamecnik, ... bioRxiv, 2020 | 16 | 2020 |
| Killer cell immunoglobulin-like receptor variants are associated with protection from symptoms associated with more severe course in Parkinson disease KM Anderson, DG Augusto, R Dandekar, H Shams, C Zhao, T Yusufali, ... The Journal of Immunology 205 (5), 1323-1330, 2020 | 15 | 2020 |
| CAR-T Cell–Mediated B-Cell Depletion in Central Nervous System Autoimmunity S Gupta, M Simic, SA Sagan, C Shepherd, J Duecker, RA Sobel, ... Neurology: Neuroimmunology & Neuroinflammation 10 (2), e200080, 2023 | 13 | 2023 |
| Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients J Diray-Arce, S Fourati, ND Jayavelu, R Patel, C Maguire, AC Chang, ... Cell Reports Medicine 4 (6), 2023 | 12 | 2023 |
